Guorong Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guorong Wu has a total of 228 co-authors. Here are the top co-authors by number of shared publications:
- Dinggang Shen
ShanghaiTech University
35 shared publications - Qian Wang
ShanghaiTech University
24 shared publications Minjeong Kim
Department of Computer Science, University of North Carolina at Greensboro, Greensboro, NC, 27412, USA
22 shared publications- Tingting Dan
University of North Carolina at Chapel Hill
19 shared publications Tingting Dan
Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, USA
12 shared publications- Paul J. Laurienti
Wake Forest University School of Medicine, Winston-Salem, NC, USA
9 shared publications
Latest Publications
- 26 September 2026
- Published by Springer Nature
- p. 181-191
ENC-ODE: Event-level Neurodegenerative Modeling in Continuous Time with Neural ODEs
- 26 September 2026
- Published by Springer Nature
- p. 181-191
ENC-ODE: Event-level Neurodegenerative Modeling in Continuous Time with Neural ODEs
- Open Access
- 29 July 2026
- Published by Springer Nature in npj Digital Medicine
Understanding mechanistic role of structural and functional connectivity in tau propagation through multilayer modeling
- 29 July 2026
- Published by Springer Nature in npj Digital Medicine
Open AccessUnderstanding mechanistic role of structural and functional connectivity in tau propagation through multilayer modeling
- Open Access
- 8 July 2026
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 23 (240)
Optimal control for anti-abeta treatment in Alzheimer’s disease using a reaction–diffusion model
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that severely impairs survival and quality of life. While anti-amyloid beta (Aβ) therapies can slow disease progression, their efficacy depends on personalized dosing that maximizes benefits and minimizes risks, such as amyloid-related imaging abnormalities (ARIA). Mathematical modelling offers a powerful tool for understanding AD dynamics and optimizing treatment, yet most models focus solely on temporal behaviour, overlooking spatial heterogeneity within the brain. In this study, we propose a spatially explicit reaction–diffusion model to describe Aβ plaque dynamics. We formulate an optimal control problem to minimize plaque concentration while balancing therapeutic efficacy and treatment risk. Under reasonable assumptions, we establish well-posedness and uniqueness of the optimal solution. A finite element method (FEM)-based numerical framework is developed to compute personalized treatment strategies. Our model is calibrated using longitudinal Aβ positron emission tomography (PET) data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), enabling estimation of patient-specific parameters, such as growth rate and effective diffusivity. Results show that optimized treatment strategies consistently outperform constant dosing regimens across patient groups, achieving substantial reductions in cumulative amyloid burden while minimizing side effects. This integrated, data-driven framework advances personalized, spatially informed therapeutic optimization for AD.
- 8 July 2026
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 23 (240)
Open AccessOptimal control for anti-abeta treatment in Alzheimer’s disease using a reaction–diffusion model
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that severely impairs survival and quality of life. While anti-amyloid beta (Aβ) therapies can slow disease progression, their efficacy depends on personalized dosing that maximizes benefits and minimizes risks, such as amyloid-related imaging abnormalities (ARIA). Mathematical modelling offers a powerful tool for understanding AD dynamics and optimizing treatment, yet most models focus solely on temporal behaviour, overlooking spatial heterogeneity within the brain. In this study, we propose a spatially explicit reaction–diffusion model to describe Aβ plaque dynamics. We formulate an optimal control problem to minimize plaque concentration while balancing therapeutic efficacy and treatment risk. Under reasonable assumptions, we establish well-posedness and uniqueness of the optimal solution. A finite element method (FEM)-based numerical framework is developed to compute personalized treatment strategies. Our model is calibrated using longitudinal Aβ positron emission tomography (PET) data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), enabling estimation of patient-specific parameters, such as growth rate and effective diffusivity. Results show that optimized treatment strategies consistently outperform constant dosing regimens across patient groups, achieving substantial reductions in cumulative amyloid burden while minimizing side effects. This integrated, data-driven framework advances personalized, spatially informed therapeutic optimization for AD.
- 22 May 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Pattern Analysis and Machine Intelligence
- Vol. PP (01628828) , 1-12
A Variational Mean-Field Control Framework for Graph Representation Learning
Feature representation learning in graph neural networks (GNNs) is a dynamic process driven by progressive information exchange throughout the graph. Current GNNs typically apply pre-defined message-passing heuristics uniformly across all graph data, even when the assumed relational inductive bias conflicts with the intrinsic graph properties (e.g., heterophily). This limitation hinders a principled understanding of graph learning and motivates a shift from application-specific architectures toward a generalizable paradigm. In this work, we conceptualize GNN learning through the lens of mean-field control, where the desired learning outcome corresponds to a variational critical point, each node reaches a representation that is adaptively calibrated to both itself and the entire graph. Building on this formulation, we propose a mathematical framework based on mean-field control (MFC) to adaptively design GNNs for unseen graph data. Specifically, we jointly optimize two control patterns: diffusive mobility, governing information propagation across the graph, and reactive mobility, regulating feature transformation at individual nodes. Both controls are learned from each input instance by solving an MFC variational problem through Hamiltonian flows characterized by partial differential equations (PDE). Our variational framework unifies existing PDE-based GNNs as special mean-field games with fixed control patterns, and yields an end-to-end deep model, termed Nash-GNN. Extensive experiments show that Nash-GNN achieves state-of-the-art performance across diverse benchmarks, including heterophilic graphs and human connectomes. Beyond empirical gains, the MFC framework offers a principled lens to examine the mechanisms of graph representation learning through collective dynamics, opening promising directions for next-generation GNN design.
- 22 May 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Pattern Analysis and Machine Intelligence
- Vol. PP (01628828) , 1-12
A Variational Mean-Field Control Framework for Graph Representation Learning
Feature representation learning in graph neural networks (GNNs) is a dynamic process driven by progressive information exchange throughout the graph. Current GNNs typically apply pre-defined message-passing heuristics uniformly across all graph data, even when the assumed relational inductive bias conflicts with the intrinsic graph properties (e.g., heterophily). This limitation hinders a principled understanding of graph learning and motivates a shift from application-specific architectures toward a generalizable paradigm. In this work, we conceptualize GNN learning through the lens of mean-field control, where the desired learning outcome corresponds to a variational critical point, each node reaches a representation that is adaptively calibrated to both itself and the entire graph. Building on this formulation, we propose a mathematical framework based on mean-field control (MFC) to adaptively design GNNs for unseen graph data. Specifically, we jointly optimize two control patterns: diffusive mobility, governing information propagation across the graph, and reactive mobility, regulating feature transformation at individual nodes. Both controls are learned from each input instance by solving an MFC variational problem through Hamiltonian flows characterized by partial differential equations (PDE). Our variational framework unifies existing PDE-based GNNs as special mean-field games with fixed control patterns, and yields an end-to-end deep model, termed Nash-GNN. Extensive experiments show that Nash-GNN achieves state-of-the-art performance across diverse benchmarks, including heterophilic graphs and human connectomes. Beyond empirical gains, the MFC framework offers a principled lens to examine the mechanisms of graph representation learning through collective dynamics, opening promising directions for next-generation GNN design.
- 12 April 2026
- Published by Elsevier in Medical Image Analysis
- Vol. 112, 104081
Geo-Mamba: Geometry-informed state-space learning of functional brain organization
- 12 April 2026
- Published by Elsevier in Medical Image Analysis
- Vol. 112, 104081
Geo-Mamba: Geometry-informed state-space learning of functional brain organization
- Open Access
CellPheno: A High-throughput Computational Platform for Quantifying Cellular Resolution Whole Brain Microscopy Images
Advances in tissue clearing and light-sheet microscopy enable cellular resolution whole-brain 3D imaging. However, whole-brain quantification tools do not yet meet demands for efficiency or assess morphometry. Here we present CellPheno , a 3D nuclei instance segmentation framework for high-throughput cellular phenotyping. CellPheno quantifies an entire P4 mouse brain within 15 hours. We showcase whole-brain morphometry, enhanced stitching, and co-localization across multiple cell types in 53 brains.
Open AccessCellPheno: A High-throughput Computational Platform for Quantifying Cellular Resolution Whole Brain Microscopy Images
Advances in tissue clearing and light-sheet microscopy enable cellular resolution whole-brain 3D imaging. However, whole-brain quantification tools do not yet meet demands for efficiency or assess morphometry. Here we present CellPheno , a 3D nuclei instance segmentation framework for high-throughput cellular phenotyping. CellPheno quantifies an entire P4 mouse brain within 15 hours. We showcase whole-brain morphometry, enhanced stitching, and co-localization across multiple cell types in 53 brains.
- 10 February 2026
- Published by Annual Reviews in Annual Review of Biomedical Engineering
Teravoxel Microscopy Image Analysis for Neurological Diseases
Light-sheet fluorescence microscopy (LSFM) has emerged as a revolutionary imaging modality for investigating intact three-dimensional brain structures at the teravoxel scale. In parallel, high-throughput computational methods, especially deep learning approaches, have opened new avenues for uncovering the pathophysiological mechanisms of neurological diseases through LSFM technology. Recent advances in optics and tissue clearing methods have allowed whole-brain imaging at cellular resolution in three dimensions, and the integration of artificial intelligence has facilitated the identification of disease-related cellular profiles and morphological markers. Machine learning techniques for stitching, segmentation, classification, super-resolution, and registration, therefore, are promoted to uncover biological patterns that are not visible to human eyes yet are related to neuroinflammatory and neurodegenerative diseases. However, analytic pipelines have been designed differently for various animal models and brain structures, leading to challenges in feasibility and compatibility within this emerging field of data-driven LSFM image analysis. Here, we present an overview of current pipelines, examine existing and forthcoming challenges as the LSFM community advances, demonstrate their implications for neurological disease applications, and propose potential solutions.
- 10 February 2026
- Published by Annual Reviews in Annual Review of Biomedical Engineering
Teravoxel Microscopy Image Analysis for Neurological Diseases
Light-sheet fluorescence microscopy (LSFM) has emerged as a revolutionary imaging modality for investigating intact three-dimensional brain structures at the teravoxel scale. In parallel, high-throughput computational methods, especially deep learning approaches, have opened new avenues for uncovering the pathophysiological mechanisms of neurological diseases through LSFM technology. Recent advances in optics and tissue clearing methods have allowed whole-brain imaging at cellular resolution in three dimensions, and the integration of artificial intelligence has facilitated the identification of disease-related cellular profiles and morphological markers. Machine learning techniques for stitching, segmentation, classification, super-resolution, and registration, therefore, are promoted to uncover biological patterns that are not visible to human eyes yet are related to neuroinflammatory and neurodegenerative diseases. However, analytic pipelines have been designed differently for various animal models and brain structures, leading to challenges in feasibility and compatibility within this emerging field of data-driven LSFM image analysis. Here, we present an overview of current pipelines, examine existing and forthcoming challenges as the LSFM community advances, demonstrate their implications for neurological disease applications, and propose potential solutions.
- 5 February 2026
- Published by Elsevier in Information Sciences
- Vol. 740
Machine learning on dynamic functional connectivity: Promise, pitfalls, and interpretations
- 5 February 2026
- Published by Elsevier in Information Sciences
- Vol. 740
Machine learning on dynamic functional connectivity: Promise, pitfalls, and interpretations
- 8 January 2026
- Published by Elsevier in Medical Image Analysis
- Vol. 109, 103931
NeuroDetour: A neural pathway transformer for uncovering structural-functional coupling mechanisms in human connectome
- 8 January 2026
- Published by Elsevier in Medical Image Analysis
- Vol. 109, 103931
NeuroDetour: A neural pathway transformer for uncovering structural-functional coupling mechanisms in human connectome